Mercury Laboratories (BOM:538964) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:538964 Mercury Laboratories Ltd BOM:538964
76 GF Score
Price ₹812.50
GF Value ₹832.71
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Mercury Laboratories Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

BOM:538964
76GF Score
Mercury Laboratories Ltd BOM:538964
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mercury Laboratories (BOM:538964) Overvalued in 2026?

Based on GuruFocus' analysis, Mercury Laboratories stock appears to be undervalued. The current stock price of ₹812.50 is trading 2.4% below its estimated GF Value™ of ₹832.71. GuruFocus considers Mercury Laboratories to be Fairly Valued.

Key valuation signals for BOM:538964:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹832.71 vs. price of ₹812.50 (2.4% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BOM:538964 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mercury Laboratories Business Description

Address Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and Internationally, of which key revenue is derived from sales made in India.
76GF Score

Get the complete analysis for BOM:538964

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹812.50
Price
₹832.71
GF Value